MedPath
TGA Approval

Bonspri Ofatumumab 20 mg/0.4mL solution for injection pre-filled pen (381104)

381104

Bonspri Ofatumumab 20 mg/0.4mL solution for injection pre-filled pen

Novartis Pharmaceuticals Australia Pty Ltd

January 27, 2022

Medicine

Medicine

Active

Registered

Active Ingredients

Ofatumumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bonspri Ofatumumab 20 mg/0.4mL solution for injection pre-filled pen (381104) - TGA 批准文号 | MedPath